Skip to main content
. 2016 Jul 27;21(8):931. doi: 10.3390/molecules21080931

Table 2.

Studies evaluating capsaicin anticancer effect in vivo.

Animal Model Capsaicin Doses Treatment Results Ref.
BALB/cJ and BALB/cJ nu/un mice injected with live tumor cells CT26 100–200 μg Intratumoral on Days 5, 10 and 15 Retarded progression of injected tumors [81]
BNX nu/un male mice mice injected with PC-3 cells 5 mg/kg/day Gavage 3 days per week for 4 weeks Reduced tumor growth [53]
Athymic nude mice injected with PC-3 cells 5 mg/kg body weight Subcutaneous injection every two days for 14 days Suppressed PC-3 tumor growth and induced apoptosis [51]
Female athymic nude mice injected subcutaneously with AsPC-1 tumor cells 2.5 mg/kg body weight Five times a week Suppressed growth of tumor xenografts without adverse effects [61]
5 mg/kg body weight Three times a week [61]
Male athymic nu/nu mice injected with U266 cells 1 mg/kg Twice a week for 3 weeks Inhibited growth of U266 xenograft tumors [60]
Male Athymic nude mice injected subcutaneously with T24 cells 5 mg/kg Subcutaneous injection every 3 days for 4 weeks Slowed growth of xenograph tumors [67]
Female triple deficient beige/nude/xid mice (BNX) injected with MDA-MB231 cells 5 mg/kg Oral gavage 3 days per week for 4 weeks Decrease the size of tumors by 50% [46]
Male nude mice injected subcutaneously with H69 cells 10 mg/kg body weight Solid diet until tumors of the control group reached 2000 mm3 Tumor growth suppression [68]
Female BALB/c athymic nude mice injected subcutaneously with Colo 205 cells 1 mg/kg Intraperitoneal injected. Four weeks of treatment Inhibition of tumor growth [46]
3 mg/kg
Female athymic nude mice injected subcutaneously with AsPC-1 tumor cells 2.5 mg/kg Orally fed 5 days a week for 6 weeks Reduced tumor SOD activity by 60% and increased the ratio of oxidized glutathione to glutathione [62]
Male BALB/c (nu/nu) athymic nude mice injected subcutaneously with PANC-1 cells 5 mg/kg body weight Gavage 3 days per week for 4 weeks Inhibited the growth of pancreatic cancer PANC-1 cell xenografts. [41]